The use of omalizumab in allergen immunotherapy

Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy

(2017) Pamela A. Frischmeyer-Guerrerio et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics

(2017) Phillip L. Lieberman et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Omalizumab facilitates rapid oral desensitization for peanut allergy

(2017) Andrew J. MacGinnitie et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Oral Immunotherapy for Food Allergy

(2017) RA Wood   JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

Combining anti-IgE with oral immunotherapy

(2017) Chunrong Lin et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Immunotherapy for Food Allergy: Are We There Yet?

(2017) Yael Gernez et al.   Journal of Allergy and Clinical Immunology-In Practice

Treatment with a Combination of Omalizumab and Specific Immunotherapy for Severe Anaphylaxis after a Wasp Sting

(2017) K. Pałgan et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Oral Immunotherapy for Food Allergy

(2016) Allison J. Burbank et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Identification of IgE

(2016) Kimishige Ishizaka et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Food allergen immunotherapy: Current status and prospects for the future

(2016) Robert A. Wood   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The discovery of IgE

(2016) S.G.O. Johansson   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy

(2016) Robert A. Wood et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Anti-IgE-assisted desensitization to egg and cow's milk in patients refractory to conventional oral immunotherapy

(2016) C. Martorell-Calatayud et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Wheat oral immunotherapy for wheat-induced anaphylaxis

(2015) Sakura Sato et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Possible recurrence of symptoms after discontinuation of omalizumab in anti-IgE-assisted desensitization to egg

(2014) Isabel Lafuente et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Omalizumab in Asthma: An Update on Recent Developments

(2014) Marc Humbert et al.   Journal of Allergy and Clinical Immunology-In Practice

AAAAI/ACAAI Surveillance Study of Subcutaneous Immunotherapy, Years 2008-2012: An Update on Fatal and Nonfatal Systemic Allergic Reactions

(2014) Tolly G. Epstein et al.   Journal of Allergy and Clinical Immunology-In Practice

Reducing and managing systemic reactions to immunotherapy

(2013) Anupama Ravi et al.   Current Opinion in Allergy and Clinical Immunology

Anti-IgE – emerging opportunities for Omalizumab

(2013) K Suresh Babu et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients

(2013) Lynda C. Schneider et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy

(2013) Matthias Volkmar Kopp et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome

(2013) Elizabeth Nicole da Silva et al.   Journal of Allergy and Clinical Immunology-In Practice

Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy

(2012) Jessica H. Savage et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Oral desensitization as a useful treatment in 2-year-old children with cow's milk allergy

(2011) A. Martorell et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Safety of hymenoptera venom immunotherapy: a systematic review

(2011) Cristoforo Incorvaia et al.   EXPERT OPINION ON PHARMACOTHERAPY

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy

(2011) Hugh A. Sampson et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergy

(2011) Kari C. Nadeau et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The safety and efficacy of sublingual and oral immunotherapy for milk allergy

(2011) Corinne A. Keet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

(2011) William W. Busse et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Prevalence, Severity, and Distribution of Childhood Food Allergy in the United States

(2011) R. S. Gupta et al.   PEDIATRICS

Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study

(2010) Giovanni Battista Pajno et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Diagnosing and Managing Common Food Allergies

(2010) Jennifer J. Schneider Chafen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase†

(2010) Franziska Ruëff et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma

(2010) Marc Massanari et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergen immunotherapy: A practice parameter third update

(2010) Linda Cox et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The natural history and epidemiology of insect venom allergy: clinical implications

(2009) M. B. Bilò et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy

(2009) Satya D. Narisety et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Safety of a peanut oral immunotherapy protocol in children with peanut allergy

(2009) Alison M. Hofmann et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously

(2009) Wolfgang Kamin et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

ALLERGY Net: High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis

(2008) K. Kontou-Fili   ALLERGY

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma

(2008) M. V. Kopp et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Specific oral tolerance induction in children with very severe cow's milk–induced reactions

(2008) Giorgio Longo et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Anti-Immunoglobulin E Therapy

(2008) Manav Segal et al.   World Allergy Organization Journal